FD
SLS icon

Financial Designs’s SELLAS Life Sciences SLS Stock Holding History

Financial Designs’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$344K Hold
23,327
– – 0.18% 29
2026
Q1 		$98.7K Buy
+23,327
New +$104K 0.05% 40

Other funds holding SLS

DI
DAGCO Inc Westlake, Ohio $541M AUM 29.31% 1-Year Est. Return
OCG
Opus Capital Group Cincinnati, Ohio $1.03B AUM 20.67% 1-Year Est. Return
EFG
Everhart Financial Group Dublin, Ohio $1.56B AUM 34.29% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
Daiwa Securities Group
Daiwa Securities Group Tokyo, Japan $51.1B AUM 35.55% 1-Year Est. Return
FWA
Fulcrum Wealth Advisors Bellevue, Washington $131M AUM
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
IW
Instrumental Wealth Tampa, Florida $198M AUM 24.07% 1-Year Est. Return

Financial Designs's SLS Position: Q2 2026 in Review

Financial Designs held its SELLAS Life Sciences (SLS) position steady in Q2 2026 at 23,327 shares worth $344K. The position accounts for 0.18% of the portfolio, ranked #29.

Financial Designs first reported a position in SLS in Q1 2026 and has held it in 2 quarters since. 48 funds tracked by Wall St. Rank hold SLS as of Q2 2026.

  • Financial Designs held 23,327 shares of SELLAS Life Sciences worth $344K as of Q2 2026.
  • Financial Designs left its SELLAS Life Sciences share count unchanged in Q2 2026.
  • SELLAS Life Sciences made up 0.18% of Financial Designs's portfolio in Q2 2026, its #29 holding.
  • Financial Designs first reported a position in SELLAS Life Sciences in Q1 2026 and has held it in 2 quarters since.
  • 48 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q2 2026.

Based on Financial Designs's 13F filing for Q2 2026, filed 10 Jul 2026.